Plain-English translation of NCT06163924 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing whether a coordinated, team-based approach to heart health care can help protect prostate cancer patients who are receiving androgen deprivation therapy (ADT)—a common hormone treatment. Researchers want to understand how closely monitoring your heart, checking for warning signs, and treating any problems early can reduce heart disease risk in men on this therapy.
While this medication has greatly improved survival for prostate cancer patients, doctors have noticed it can increase the risk of heart problems over time. This study exists to figure out the best way to catch and prevent these heart risks before they become serious, and to help doctors create better guidelines for caring for this growing patient population.
You likely qualify if…
You likely don't qualify if…
As a participant, you would be evaluated at baseline to assess your current heart health and risk factors, then monitored closely throughout your hormone therapy treatment. This likely involves regular heart health assessments, blood tests, and possibly imaging or other cardiac evaluations at scheduled clinic visits over the course of your treatment, allowing doctors to track any changes and intervene early if needed.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
Hong Kong